Global Head of Bladder Cancer Team

At Johnson & Johnson, we believe health is everything.

Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com

Job Function:
Medical Affairs Group

Job Sub Function:
Medical Affairs – MD

Job Category:
People Leader

All Job Posting Locations:
Raritan, New Jersey, United States of America

Job Description:

Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements.

Visionaries like you work on teams that save lives by developing the medicines of tomorrow.  Our Oncology team is focused on the elimination of cancer by discovering new pathways and modalities to finding treatments and cures.

We lead where medicine is going and need innovators with an unwavering commitment to results.

Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.

Learn more at https://www.jnj.com/innovative-medicine

The Global Head of Bladder Cancer will be responsible for leading the Global Bladder Medical Affairs team and leading the clinical-commercial optimization of our Bladder portfolio, with a specific focus on TAR-200 and TAR-210 product development, life cycle management and overall medical strategy and tactical plans to achieve the most optimal and appropriate use of our medicines.

The Global Head of Bladder will partner closely with the Regional Medical leaders to address the needs of the regions/countries and ultimately patients, as well as the cross-functional partners from R&D / Clinical Development, Commercial, Market Access and many other key functions to develop an integrated global medical affairs perspectives, strategies and plans.

They will work closely with both commercial and R&D DAS leaders along with the late-stage R&D head for solid tumors.

The Global Head of Bladder will guide the team through the development of the strategic and tactical plans and will be a key point of contact to develop an integrated bladder strategy across assets being developed in this area.

They will also work with the prostate cancer team to ensure one GU strategy is in place, including one external engagement plan with urologists and medical oncologists straddling across bladder and prostate cancer.

 

 The GMALs reporting to the Global Head of Bladder will deliver World Wide Medical Affairs Strategic Plans, Worldwide Integrated Evidence Generation Plans, Medical communication and education plans.

With each compound focused GMALs being part of the cross-functional 3M (medical-marketing and m...